Akèy › Limfadenopati Imunoblastik › Michigan › Ann Arbor
Etid klinik pou Limfadenopati Imunoblastik nan Ann Arbor, MI
3 etid pou Limfadenopati Imunoblastik ap chèche patisipan nan sit nan ak bò kote Ann Arbor (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing the Addition of Duvelisib or CC-486 to the Usual Treatment for Peripheral T-Cell Lymphoma
Ap rekriteFaz 2
- Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · 18 mi lwen
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
Ap rekriteFaz 3
- Roger Cancer Center University of Michigan Health, Ann Arbor
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
Ap rekriteFaz 1
- University of Michigan, Ann Arbor
Etid Limfadenopati Imunoblastik nan lòt vil
- New York City, NY5 etid
- Chicago, IL4 etid
- Houston, TX4 etid
- Miami, FL4 etid
- Durham, NC4 etid
- Baldwin Park, CA3 etid
- New Haven, CT3 etid
- Columbus, OH3 etid
- Atlanta, GA3 etid
- Boston, MA3 etid
- St. Louis, MO3 etid
- Rochester, MN3 etid
Lòt etid nan Ann Arbor
- Kansè pwostat27 etid
- Kansè nan tete26 etid
- Kansè Poumon ki pa ti selil26 etid
- Kansè (tout kalite)25 etid
- Kansè kolorektal23 etid
- Kansè poumon23 etid
- Ensifizyans kadyak22 etid
- Leksemi mieloïd egi17 etid
- Maladi kadyovaskilè16 etid
- Kansè pankreyas14 etid
- Melanom12 etid
- Kansè renn (Kasinom selil renn)12 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.